6/24/2022  9:53:56 PM Chg. +7.950 Volume Bid9:59:58 PM Ask9:59:58 PM Market Capitalization Dividend Y. P/E Ratio
165.200EUR +5.06% 12,157
Turnover: 1.99 mill.
164.900Bid Size: 100 166.450Ask Size: 100 21.45 bill.EUR 1.11% 23.61

Business description

Merck is a leading science and technology company in healthcare, life science and performance materials. Around 52,000 employees work to further develop technologies that improve and enhance life – from biopharmaceutical therapies to treat cancer or multiple sclerosis, cutting-edge systems for scientific research and production, to liquid crystals for smartphones and LCD televisions. Founded in 1668, Merck is the world's oldest pharmaceutical and chemical company. The founding family remains the majority owner of the publicly listed corporate group. Merck, Darmstadt, Germany holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the company operates as EMD Serono, MilliporeSigma and EMD Performance Materials.
 

Management board & Supervisory board

CEO
Belén Garijo
Management board
Marcus Kuhnert, Dr. Kai Beckmann, Matthias Heinzel, Peter Guenter
Supervisory board
Dr. Wolfgang Büchele, Sascha Held, Alexander Putz, Anne Lange, Christian Raabe, Daniel Thelen, Dietmar Oeter, Edeltraud Glänzer, Gabriele Eismann, Helene von Roeder, Helga Rübsamen-Schaeff, Jürgen Glaser, Michael Kleinemeier, Peter Emanuel Merck, Renate Koehler, Simon Thelen
 

Company data

Name: Merck KGaA
Address: Frankfurter Str. 250,D-64293 Darmstadt
Phone: +49-6151-72-0
Fax: +49-6151-72-2000
E-mail: service@merckgroup.com
Internet: www.merck.de
Industry: Healthcare
Sector: Pharmaceutical Industry
Sub sector: Pharmaceuticals
End of financial year: 12/31
Free Float: 66.78%
IPO date: 10/20/1995

Investor relations

Name: Constantin Fest
IR phone: +49-6151-72-3321
IR Fax: +49-6151-72-91-3321
IR e-mail: investor.relations@m...oup.com investor.relations@merckgroup.com

Company calendar

CW 32 | 8/4/2022 Interim Report 2nd Quarter/6 Months
CW 46 | 11/10/2022 Interim Report 3rd Quarter/9 Months
 

Main Shareholders

Freefloat
 
66.78%
BlackRock, Inc.
 
6.81%
State Street Corporation
 
3.00%
Sun Life Financial
 
3.00%
Crédit Agricole S.A
 
3.00%
Deutsche Bank
 
3.00%
Templeton Global Advisors Limited
 
2.98%
Select Equity Group L.P.
 
2.97%
DWS Investment GmbH
 
2.95%
Others
 
5.51%